XTAI
3052
Market cap67mUSD
Oct 07, Last price
10.50TWD
1D
0.48%
1Q
-3.67%
Jan 2017
34.10%
Name
Apex Science & Engineering Corp
Chart & performance
P/E
9.55
P/S
0.63
EPS
1.10
Div yield, %
4.76%
Shrs. gr., 5y
—
Rev. gr., 5y
-8.10%
Revenues
3.42b
+28.59%
Net income
224m
+12.25%
CFO
1.80b
+378.09%
Dividend
Sep 01, 20260.6 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Apex Science & Engineering Corp. is an internationally operating enterprise specializing in a diverse range of engineering, construction, and manufacturing services. The company delivers comprehensive engineering solutions, encompassing mechanical, electrical, instrumentation, and environmental engineering fields. Beyond its core engineering capabilities, Apex develops various optoelectronic products and provides bespoke LCD and LED display technologies to its clientele. The firm also undertakes an extensive array of construction projects, including industrial facilities, residential and commercial structures, civil and structural works, and crucial water conservancy initiatives. To further support its clients, Apex offers expert engineering consultancy and vital after-sales services. Established in 1976, Apex Science & Engineering Corp. is headquartered in New Taipei City, Taiwan.
Key people
Guohua Guo
Chairman of the Board, General Manager · since 2006
Deyuan Chen
Deputy General Manager-Engineering Business · since 2011
Xiuwen Fan
Deputy General Manager-Administration Management · since 2020
Wuyuan Peng
Deputy General Manager-Engineering Business · since 2005
Shibo Peng
General Manager-Construction Business Division · since 2020
Xiuling Wu
Head of Finance & Accounting · since 2020
Fangyuan Lu
Director · since 2018
Zhaogui Wang
Director · since 2021
Xiyang Zhou
Director · since 2018
Independent Director
Nai-Hua Wu
Independent Director
Sheng-Xian Xiao
Independent Director
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||